Strategies for Enhancing Participation in Clinical Trials

1

Clinical trials are essential for advancing cancer treatment, yet most US adults receiving cancer care do not participate in them.
2

A study analyzed 205,743 adults with advanced cancer, revealing only 5.2% received a clinical study drug from 2011 to 2024.
3

Participation in clinical trials is concentrated among a small percentage of physicians and practices, with 29.7% of physicians enrolling no patients.
4

Barriers to clinical trial participation include structural issues, such as lack of available trials and disqualifying eligibility criteria.
5

To improve trial access, interventions must be tailored to the specific needs of practices with varying levels of trial participation.

1